title: An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy.
abstract: OBJECTIVE
  The Glycine389 variant of the beta-1 adrenergic receptor generates markedly less cAMP when stimulated in vitro than the more prevalent Arginine389 variant and may confer protection against coronary events similar to that observed with beta-blockers. The aim of this study was to ascertain whether this Glycine389 variant protects against coronary events.
  
  
  RESULTS
  We identified the genotype at position 389 of the beta1AR in 1554 individuals taken from men enrolled in the West of Scotland Coronary Prevention Study. Men with a coronary event (event group) were each matched for age and smoking status with two control subjects from the same cohort who had not had a coronary event (control group). We compared the distribution of genotypes in the event and control groups. Conditional logistic regression was used to calculate odds ratios for each of the genotypes. The prevalence of the three genotypes in the entire cohort was ArgArg 53.5%, ArgGly 39.6%, GlyGly 6.9%. The Arg389Gly beta-1 adrenergic receptor polymorphism was not associated with coronary events. Using the ArgArg genotype as the reference, the odds ratio for the ArgGly genotype was 1.1 (95% CI, 0.88-1.38) and for the GlyGly genotype it was 1.05 (95% CI, 0.68-1.62).
  
  
  CONCLUSIONS
  Our longitudinal case-control study demonstrates that the Glycine389 variant of the beta-1 adrenergic receptor does not protect against coronary events.
authors.affiliation: Institute for Cardiovascular Research, University of Leeds, UK.
authors.forename: H L
authors.initials: HL
authors.lastname: White
authors.forename: A
authors.initials: A
authors.lastname: Maqbool
authors.forename: A D
authors.initials: AD
authors.lastname: McMahon
authors.forename: L
authors.initials: L
authors.lastname: Yates
authors.forename: S G
authors.initials: SG
authors.lastname: Ball
authors.forename: A S
authors.initials: AS
authors.lastname: Hall
authors.forename: A J
authors.initials: AJ
authors.lastname: Balmforth
mesh_terms: D000328:Adult; D000483:Alleles; D001483:Base Sequence; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D016001:Confidence Intervals; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009203:Myocardial Infarction / Q000235:genetics* / Q000503:physiopathology; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018342:Receptors, Adrenergic, beta-1 / Q000032:analysis / Q000235:genetics*; D012680:Sensitivity and Specificity
chemical_list: D018342:Receptors, Adrenergic, beta-1